Following a disappointing earnings showing from Eli Lilly last week, Novo Nordisk’s latest report on the performance of its ...

As the FDA issues a new warning about aspiration across all GLP-1 weight loss drugs, doctor groups are giving new recommendations.

The FDA has updated the labels for all GLP-1 receptor agonists, including popular medications Ozempic, Wegovy, Saxenda and Mounjaro, to include a new warning about the risk of pulmonary aspiration ...

Share on Pinterest A recent study found significant reductions in opioid overdose and alcohol misuse among people taking GLP-1 drugs like Ozempic. FreshSplash/Getty Images A new study shows a 50% ...

The new menu includes five smoothies “created to assist the millions of Americans currently taking prescription GLP-1 medications" Sabrina ... medications — like Ozempic and Wegovy — anyone ...

Originally intended as a treatment for diabetes, GLP-1 drugs like Ozempic could be set to turn the food and drink industry ...

This is just a glimpse of the GLP-1 insights available to CivicScience clients. Want to see the full picture? Let’s talk.

GLP-1 plays an important role in regulating ... 13,724 of the participants had a prescription for Ozempic, Mounjaro, or a similar weight loss medication. A pack of semaglutide injections with ...

Among the findings, the report published Monday highlights the impact of Ozempic, other GLP-1 drugs and hormones used in gender-affirming care and lays out sex- and gender-specific risks of stroke.

While they are marketed as being for people taking diabetes and obesity medications — like Ozempic and Wegovy — anyone ...

The findings also show that people with opioid use disorder taking GLP-1 drugs like Ozempic had a 40% lower chance of an opioid overdose. The study authors explained the medications interact with ...